Novartis receives FDA approval for Egaten - BSA bureau
Novartis receives FDA approval for Egaten BSA bureau
Egaten is currently the only medicine for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines.
Egaten is currently the only medicine for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines.
Comments
Post a Comment